Related Experiment Video
Updated: May 17, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skin
Shadmehr Demehri1, Ahu Turkoz, Sindhu Manivasagam
1Department of Developmental Biology and Division of Dermatology, Washington University School of Medicine, Box 8103, 660 South Euclid Avenue, St. Louis, MO 63110-1095, USA. demehris@wustl.edu
Abstract:
Thymic Stromal Lymphopoietin (TSLP), a cytokine implicated in induction of T helper 2 (Th2)-mediated allergic inflammation, has recently been shown to stimulate solid tumor growth and metastasis. Conversely, studying mice with clonal loss of Notch signaling in their skin revealed that high levels of TSLP released by barrier-defective skin caused a severe inflammation, resulting in gradual elimination of Notch-deficient epidermal clones and resistance to skin tumorigenesis. We found CD4(+) T cells to be both required and sufficient to mediate these effects of TSLP. Importantly, TSLP overexpression in wild-type skin also caused resistance to tumorigenesis, confirming that TSLP functions as a tumor suppressor in the skin.
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Clinical Applications of Epidermal Stem Cells
Abnormal Proliferation